Méthotrexate Pfizer, cpr 2.5 mg , blist 30 pce
7680285410027
CH-28541
L04AX03
1 / 2
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
66.166 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.268 MG | Substance | HBESI |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 28541
- Drug name
- Methotrexat Pfizer, Tabletten
- Galenic form
- TAB
- ATC Code
- L01BA01
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- A
- First authorization
- 19/09/1964
- Authorization expiration date
- 31/07/2025
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- METHOTREXAT Pfizer cpr 2.5 mg blist 30 pce
- Description (DE)
- METHOTREXAT Pfizer Tabl 2.5 mg Blist 30 Stk
- Market withdrawal
- 31/07/2025
- Narcotic (BTM)
- No